Forbes Magazine’s staff writers Noah Kirsch and Michela Tindera have followed Lefkofsky’s career, noting that he started several data collecting companies before Tempus.
Tempus gathers and generates data to help oncologists target cancer treatment for better patient outcome. The model may be adapted to other conditions in the future.
Although the newly minted Tempus faces challenges from competition from other data companies and the high cost of sequencing, it’s $3.1 billion valuation reflectes investor confidence in its future.
According to Kirsch and Tindera, Lefkofsky was entrepreneurial since his college days at the University of Michigan where he founded many companies.
Lefkofsky’s wife Liz’s breast cancer diagnosis was the catalyst for the start of Tempus when he was discouraged by both the lack of pertinent data and the reluctance of firms to share theirs.
Two years ago Tempus acquired one million patient records from the American Society of Clinical Oncology and soon more oncologists followed, sending records and biopsies for analysis and genome sequencing.
Kirsch and Tindera write that last year, Tempus competition increased when Roche bought a data firm and genome sequencing firm and a new startup
They observed that while some doctors who prefer lighter work are overwhelmed by the large volume of data that Tempus provides, some have joined the company in research.
Kirsch and Tindera observe that despite current challenges, Lefkofsky has an auspicious view of the future, having decided that his career choices to date have brought him to his present position. He would like to be remembered for his work in Tempus Labs. Read more about Eric Lefkofsky: https://newsblaze.com/business/latest-business/eric-lefkofsky-about-tempus-at-bloombergs-the-year-ahead-summit_146430/
Marc Beer is an iconic and legendary figure in the healthcare industry and has led to the development of new treatment methods for diseases and conditions in the medical industry. Beer has served in the industry for over three decades and has made a name for himself in the industry. Many know him as a serial entrepreneur and a healthcare startup who has founded and helped established several startups. Beer Journey in the industry began way back in the 90s when he joined Abbott Labs, a leading pharmaceutical drug and device manufacturing company. Since then, Beer has remained in the industry and has played pivotal roles in the growth and development of the healthcare industry. Some of the healthcare companies that Beer helped establish and served in senior leadership positions include Genzyme, ViaCell, and Good Start Genetics.
Marc Beer currently serves at the helm of Renovia Inc Company as CEO and Co-founder. Beer, alongside two others, founded the company in 2016. The company is a healthcare startup company that focuses on device development and commercialization. Renovia Inc., since its founding, has revolutionized the treatment of pelvic floor disorder, a health condition that in the US affects over 13 million. The firm has developed a treatment method that helps improve the lives of women without necessarily having to go through surgery. Learn more: http://professionaltales.com/the-voice-of-marc-beer-how-to-be-a-good-leader/
Marc Beer, in an interview with inspired, said that what made him join the healthcare industry was the fascination of what modern medicine could do. Modern medicine, according to Beer, does not only heal the sick but can change the very course of nature. Beer added he could not imagine that there would come a day where people with severe health conditions such as diabetes or cancer that were considered to be incurable could this day be wholly cured. To Beer, that was a miraculous thing that Beer wanted to be part of. Beer was so inspired by the amazing things that modern medicine could do and wanted to also contribute to the industry.
The idea of starting Renovia Inc Marc Beer said came from Dr. Sam Pulliam. Dr. Sam approached Beer and told him that there is a condition that affects millions of women in the US and that he and Dr. Jose Bohorquez have identified an evidence-based approach to treating the condition. The condition was pelvic floor muscle dysfunction. The two Doctors had devised a treatment method that did not require surgery, and Beer thought it was an excellent Idea. The Doctors wanted someone with both the technical know-how as well as top managerial skills, and they could think of no one else but Beer. Beer ever since founding the company has been very pivotal in providing leadership and has helped the firm in securing both Series A and Series B funding.
Follow Marc Beer onFacebook